155 related articles for article (PubMed ID: 29694357)
1. Development of a statistical model for cervical cancer cell death with irreversible electroporation in vitro.
Yang Y; Moser MAJ; Zhang E; Zhang W; Zhang B
PLoS One; 2018; 13(4):e0195561. PubMed ID: 29694357
[TBL] [Abstract][Full Text] [Related]
2. A statistical model for multidimensional irreversible electroporation cell death in tissue.
Golberg A; Rubinsky B
Biomed Eng Online; 2010 Feb; 9():13. PubMed ID: 20187951
[TBL] [Abstract][Full Text] [Related]
3. Tumor Ablation Enhancement by Combining Radiofrequency Ablation and Irreversible Electroporation: An In Vitro 3D Tumor Study.
Zhang B; Yang Y; Ding L; Moser MAJ; Zhang EM; Zhang W
Ann Biomed Eng; 2019 Mar; 47(3):694-705. PubMed ID: 30565007
[TBL] [Abstract][Full Text] [Related]
4. Development of a thermal model for irreversible electroporation: an approach to estimate and optimize the IRE protocols.
Wardhana G; Almeida JP; Abayazid M; Fütterer JJ
Int J Comput Assist Radiol Surg; 2021 Aug; 16(8):1325-1334. PubMed ID: 34032965
[TBL] [Abstract][Full Text] [Related]
5. Treatment Planning Optimization in Irreversible Electroporation for Complete Ablation of Variously Sized Cervical Tumors: A Numerical Study.
Ding L; Moser M; Luo Y; Zhang W; Zhang B
J Biomech Eng; 2021 Jan; 143(1):. PubMed ID: 34043747
[TBL] [Abstract][Full Text] [Related]
6. Pulse Parameters and Thresholds for (ir)Reversible Electroporation on Hepatocellular Carcinoma Cells
Lindelauf KHK; Baragona M; Baumann M; Maessen RTH; Ritter A
Technol Cancer Res Treat; 2023; 22():15330338221136694. PubMed ID: 36600679
[TBL] [Abstract][Full Text] [Related]
7. Analysis on reversible/irreversible electroporation region in lung adenocarcinoma cell model in vitro with electric pulses delivered by needle electrodes.
Lv Y; Tang X; Peng W; Cheng X; Chen S; Yao C
Phys Med Biol; 2020 Nov; 65(22):225001. PubMed ID: 33053520
[TBL] [Abstract][Full Text] [Related]
8. Cancer cells ablation with irreversible electroporation.
Miller L; Leor J; Rubinsky B
Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
[TBL] [Abstract][Full Text] [Related]
9. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction.
Arena CB; Sano MB; Rossmeisl JH; Caldwell JL; Garcia PA; Rylander MN; Davalos RV
Biomed Eng Online; 2011 Nov; 10():102. PubMed ID: 22104372
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of contribution of mild and moderate hyperthermia to thermal ablation and sensitization of irreversible electroporation of pancreatic cancer cells.
Agnass P; Rodermond HM; van Veldhuisen E; Vogel JA; Ten Cate R; van Lienden KP; van Gulik TM; Franken NAP; Oei AL; Kok HP; Besselink MG; Crezee J
J Therm Biol; 2023 Jul; 115():103619. PubMed ID: 37437370
[TBL] [Abstract][Full Text] [Related]
11. Lethal Electric Field Thresholds for Cerebral Cells With Irreversible Electroporation and H-FIRE Protocols: An In Vitro Three-Dimensional Cell Model Study.
Shu T; Ding L; Fang Z; Yu S; Chen L; Moser MAJ; Zhang W; Qin Z; Zhang B
J Biomech Eng; 2022 Oct; 144(10):. PubMed ID: 35445240
[TBL] [Abstract][Full Text] [Related]
12. Predictive therapeutic planning for irreversible electroporation treatment of spontaneous malignant glioma.
Garcia PA; Kos B; Rossmeisl JH; Pavliha D; Miklavčič D; Davalos RV
Med Phys; 2017 Sep; 44(9):4968-4980. PubMed ID: 28594449
[TBL] [Abstract][Full Text] [Related]
13. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy.
Davalos RV; Bhonsle S; Neal RE
Prostate; 2015 Jul; 75(10):1114-8. PubMed ID: 25809014
[TBL] [Abstract][Full Text] [Related]
14. US findings after irreversible electroporation ablation: radiologic-pathologic correlation.
Appelbaum L; Ben-David E; Sosna J; Nissenbaum Y; Goldberg SN
Radiology; 2012 Jan; 262(1):117-25. PubMed ID: 22106355
[TBL] [Abstract][Full Text] [Related]
15. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.
Neal RE; Millar JL; Kavnoudias H; Royce P; Rosenfeldt F; Pham A; Smith R; Davalos RV; Thomson KR
Prostate; 2014 May; 74(5):458-68. PubMed ID: 24442790
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation in the eradication of rabbit VX2 cervical tumors.
Chai W; Xu Y; Zhang W; Wei Z; Li J; Shi J; Luo X; Zeng J; Cui M; Niu L
Biomed Microdevices; 2017 Oct; 19(4):90. PubMed ID: 28993931
[TBL] [Abstract][Full Text] [Related]
17. A statistical model describing combined irreversible electroporation and electroporation-induced blood-brain barrier disruption.
Sharabi S; Kos B; Last D; Guez D; Daniels D; Harnof S; Mardor Y; Miklavcic D
Radiol Oncol; 2016 Mar; 50(1):28-38. PubMed ID: 27069447
[TBL] [Abstract][Full Text] [Related]
18. The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems.
Neal RE; Davalos RV
Ann Biomed Eng; 2009 Dec; 37(12):2615-25. PubMed ID: 19757056
[TBL] [Abstract][Full Text] [Related]
19. The Enlargement of Ablation Area by Electrolytic Irreversible Electroporation (E-IRE) Using Pulsed Field with Bias DC Field.
Lv Y; Liu H; Feng Z; Zhang J; Chen G; Yao C
Ann Biomed Eng; 2022 Dec; 50(12):1964-1973. PubMed ID: 35852648
[TBL] [Abstract][Full Text] [Related]
20. Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation (IRE).
Kos B; Voigt P; Miklavcic D; Moche M
Radiol Oncol; 2015 Sep; 49(3):234-41. PubMed ID: 26401128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
